03.01.2017 Evonik Industries AG  DE000EVNK013

DGAP-News: Evonik Industries AG: Evonik successfully completes acquisition of Air Products specialty additives business


 
DGAP-News: Evonik Industries AG / Key word(s): Mergers & Acquisitions Evonik Industries AG: Evonik successfully completes acquisition of Air Products specialty additives business 03.01.2017 / 14:45 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Evonik successfully completes acquisition of Air Products specialty additives business - Transaction approved by antitrust authorities - Integration process underway - Synergies of US$80 million and tax benefits with net present value exceeding US$500 million over the coming years - Expected to increase adjusted earnings per share in the 2017 business year Essen, January 3, 2017 - Evonik Industries AG has completed the activities to acquire the specialty additives business (Performance Materials Division) of the US company Air Products, Inc. for US$3.8 billion (approx. EUR3.5 billion) by the end of the year as planned. The closing is scheduled for January 03, 2017. All relevant antitrust authorities have approved the transaction and the integration of the acquired business is underway. The transaction financing was completed successfully in September and will consist of the company's own funds in the amount EUR1.6 billion, with the other half to be financed by bonds with a nominal value of EUR1.9 billion. "The successful completion of the acquisition paves the way for swiftly merging the activities of Evonik and the acquired units of the Air Products Performance Materials business," said Klaus Engel, Chairman of the Executive Board of Evonik Industries AG. "It puts Evonik in an excellent position for further profitable growth in the attractive specialty additives market." "We are well prepared to ensure a smooth business transition and a successful integration. To this end, we have worked intensively with Air Products over the past few months to develop integration plans," confirmed Ralph Sven Kaufmann, Chief Operating Officer and Executive Board member responsible for the integration. Positive EPS in the 2017 business year The annual synergy effects in the amount of US$80 million can be confirmed at this time and should be fully realized by 2020 at the latest. Evonik expects to leverage synergies in the amount of EUR10 to 20 million in the year 2017. The acquisition is expected to increase the adjusted earnings per share (EPS) of Evonik in the 2017 business year. Since the transaction is partly structured as an asset deal, it will lead to tax benefits as a consequence of write-offs which are typical for transactions of this nature. These benefits amount to a net present value of more than US$500 million, which can be used on a prorated basis in the 2017 business year. Additional information on the Air Products Specialty & Coating Additives business The Specialty & Coating Additives business of Air Products is the Performance Materials Division within the Materials Technologies Segment of Air Products and Chemicals, Inc. It has around 1,100 employees at 11 production and development locations and offers local customer support in all key global regions. Company information Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik's corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2015 more than 33,500 employees generated sales of around EUR13.5 billion and an operating profit (adjusted EBITDA) of about EUR2.47 billion. Disclaimer In so far as forecasts or expectations are expressed in this Investor Relations News or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release. Contact: Tim Lange Head of Investor Relations +49 201 177-3150 tim.lange@evonik.com Evonik Industries AG Rellinghauser Straße 1-11 45128 Essen Germany Phone +49 201 177-01 Fax +49 201 177-3475 www.evonik.com Supervisory Board Dr. Werner Müller, Chairman Executive Board Dr. Klaus Engel, Chairman Christian Kullmann, Deputy Chairman Dr. Ralph Sven Kaufmann Thomas Wessel Ute Wolf Registered Office is Essen Register Court Essen Local Court Commercial Registry B 19474 --------------------------------------------------------------------------- 03.01.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Evonik Industries AG Rellinghauser Straße 1-11 45128 Essen Germany Phone: +49 (0) 201 177-01 Fax: +49 (0) 201 177-3475 E-mail: investor-relations@evonik.com Internet: www.evonik.com ISIN: DE000EVNK013, XS0911405784 WKN: EVNK01, A1TM7T Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Luxemburg End of News DGAP News Service --------------------------------------------------------------------------- 533825 03.01.2017


Die wichtigsten Finanzdaten auf einen Blick
  2013 2014 2015 2016 2017 2018 2019 2020e
Umsatzerlöse1 12.874,00 12.917,00 13.507,00 12.732,00 14.419,00 15.024,00 13.108,00 13.140,00
EBITDA1,2 1.995,00 1.822,00 2.465,00 2.165,00 2.357,00 2.150,00 2.153,00 2.140,00
EBITDA-Marge3 15,50 14,11 18,25 17,00 16,35 14,31 16,43 16,29
EBIT1,4 1.424,00 1.046,00 1.644,00 1.298,00 1.229,00 1.367,00 1.080,00 0,00
EBIT-Marge5 11,06 8,10 12,17 10,19 8,52 9,10 8,24 0,00
Jahresüberschuss1 2.054,00 581,00 1.019,00 762,00 734,00 954,00 2.127,00 0,00
Netto-Marge6 15,95 4,50 7,54 5,98 5,09 6,35 16,23 0,00
Cashflow1,7 1.083,00 1.066,00 1.968,00 1.758,00 1.551,00 1.704,00 1.321,00 0,00
Ergebnis je Aktie8 1,78 1,22 2,13 1,81 1,54 2,00 4,52 1,65
Dividende8 1,00 1,00 1,15 1,15 1,15 1,15 1,15 0,75
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2019 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Evonik Industries
WKN Kurs in € Einschätzung Börsenwert in Mio. €
EVNK01 22,020 Halten 10.261,32
KGV 2021e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
11,59 14,98 0,773 10,17
KBV KCV KUV EV/EBITDA
1,22 7,77 0,78 7,625
Dividende '19 in € Dividende '20e in € Div.-Rendite '19e
in %
Hauptversammlung
1,15 0,75 5,22 31.08.2020
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
07.05.2020 04.08.2020 03.11.2020 04.03.2020
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-8,26% -6,40% -19,07% -2,39%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Evonik Industries AG  ISIN: DE000EVNK013 können Sie bei DGAP abrufen

Chemie , EVNK01 , EVK , XETR:EVK